Tokyo, Japan ― September 16, 2016 ― LPixel Inc. announced today the launch of the pre-registration site for its AI-based image analysis cloud service, IMACEL. Designed for images utilized in life science research, IMACEL delivers a user-friendly, high-quality image analyzing platform to help users extract meaningful data from their images with incredible speed and efficiency. With the image analysis procedure automated and drastically simplified with the integration of advanced AI technology, IMACEL helps to accelerate life science research by enabling scientists and other healthcare professionals focus on more sophisticated research tasks.
◆IMACEL Official Website
With the rapid development of medical devices and image-capturing technology, researchers working in the life sciences field such as the medical, pharmaceutical and agricultural sectors are presented with an enormous collection of images to extract meaningful data for research and diagnostic purposes. While this manual process of image analysis gradually translated into a time-consuming task for researchers, life science images alone have increased 100 fold in the past 10 years, further increasing the workload for researchers and hindering overall research efficiency. This problem is further magnified as only 1% of researchers learn how to properly process images despite the fact that over 90% of research papers written in life science journals include images*. IMACEL is anticipated to become the de facto standard for image analysis as its easy-to-use AI-supported capabilities serves as a powerful solution to the current trend concerning the life science research industry.
IMACEL includes the following features. More features are slated to be added in the future.
AI-Supported Advanced Image Analysis
LP-Classifier: Automatic Classification Tool Integrating Machine Learning Technology
LP-exam: Technology for Detecting Falsified Images (Optional)
IMACEL was awarded with the Microsoft Innovation Award 2016. With vast support from Microsoft Japan Co., Ltd., the company was able to build IMACEL on Microsoft Azure.
IMACEL was officially released in Japan in winter 2017, and its global release is scheduled for spring 2017. LPixel will continue to make significant contributions to advance scientific research and technology both through the development of IMACEL and its knowledge, expertise and extensive history in conducting research in bio imaging technology.
LPixel is a leader in advanced image analysis and processing technology encompassing the life science field. Founded in March 2014, LPixel is dedicated to offering research facilities top-tier image analysis technologies and educational programs on preventing unintentional image fraud and plagiarism. The company is currently working with the National Cancer Center Japan to further the development of AI-based medical diagnosis software. For more information, please visit